PARA BIO FPO (ASX: PAR) Share Price and News

Why the Polynovo share price is now up 24x in 5 years

Tom Richardson | October 10, 2019 12:43pm

The Polynovo Ltd (ASX: PNV) share price is up 7% to $2.43 this lunchtime despite the biotech not releasing any specific news to the... More »

The Orthocell share price is going nuts on claims of a blockbuster medical breakthrough

Tom Richardson | October 9, 2019 3:59pm

Orthocell Ltd (ASX: OCC) is reporting a blockbuster medical breakthrough. More »

Why these ASX shares just stormed to 52-week highs

James Mickleboro | October 2, 2019 8:50am

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is one of three that just raced to 52-week highs or better... More »

Mesoblast shares halted as it asks investors to tip in another $75 million

Tom Richardson | October 1, 2019 3:18pm

Mesoblast limited (ASX: MSB) needs more capital from investors. More »

US congressman resigns over ASX insider trading penny stock scandal

Tom Richardson | October 1, 2019 12:57pm

Can you make money in penny stocks? More »

5 small-cap shares I’m watching in FY 2020

Tom Richardson | September 30, 2019 6:52pm

Serko Ltd (ASX: SKO) and 4 other small-cap ASX companies worth watching in FY20. More »

Why Nufarm, Paradigm, ResApp, & Zip Co shares charged higher today

James Mickleboro | September 30, 2019 2:10pm

The Nufarm Limited (ASX:NUF) share price and the Zip Co Ltd (ASX:Z1P) share price are two of four charging higher... More »

Paradigm reports “ground-breaking” osteoarthritis discovery: Is it the real deal?

Tom Richardson | September 30, 2019 9:23am

Paradigm Biopharmaceuticals (ASX:PAR) is looking to partner with big pharma. More »

Is Paradigm Biopharmaceuticals the share market’s next huge winner?

Tom Richardson | September 26, 2019 5:32pm

Paradigm: Buy the rumour, sell the news? More »

Why the Bionomics share price is up 40% today

Tom Richardson | September 26, 2019 4:25pm

Bionomics Ltd (ASX: BNO) looks very speculative. More »

Paradigm share price tanks despite positive clinical trial update

Tom Richardson | September 10, 2019 2:50pm

Paradigm Biopharmaceuticals Ltd (ASX: PAR) is a speccy biotech that could sink or soar. More »

Why the Mesoblast share price is going nuts today

Tom Richardson | September 10, 2019 2:34pm

Mesoblast limited (ASX: MSB) has signed an important partnership with Grünenthal. More »

Opthea share price lifts on clinical trial update: Is it a spec buy?

Tom Richardson | September 6, 2019 11:33am

Opthea Ltd (ASX: OPT) is developing clinical treatments for eye diseases. More »

Why Ausdrill, Link, Paradigm, & Village Roadshow shares raced higher today

James Mickleboro | August 29, 2019 2:22pm

The Ausdrill Limited (ASX:ASL) share price and the Village Roadshow Ltd (ASX:VRL) share price are two of four racing higher on Thursday. Here's why... More »